相似文献
1
Molecular ablation of ventricular tachycardia after myocardial infarction.
Nat Med. 2006 Nov;12(11):1256-8. doi: 10.1038/nm1503. Epub 2006 Oct 29.
2
Gene therapy approaches to ventricular tachyarrhythmias.
J Electrocardiol. 2007 Nov-Dec;40(6 Suppl):S187-91. doi: 10.1016/j.jelectrocard.2007.05.036.
3
Ventricular tachycardia from the healed myocardial infarction scar: validation of an animal model and utility of gene therapy.
Heart Rhythm. 2009 Aug;6(8 Suppl):S91-7. doi: 10.1016/j.hrthm.2009.03.048. Epub 2009 Apr 1.
4
Short QT syndrome. What is it? Where is it?
Indian Heart J. 2005 Nov-Dec;57(6):769-71.
5
Selective molecular potassium channel blockade prevents atrial fibrillation.
Circulation. 2010 Jun 1;121(21):2263-70. doi: 10.1161/CIRCULATIONAHA.109.911156. Epub 2010 May 17.
6
Short QT syndrome and atrial fibrillation caused by mutation in KCNH2.
J Cardiovasc Electrophysiol. 2005 Apr;16(4):394-6. doi: 10.1046/j.1540-8167.2005.40621.x.
7
Molecular genetic basis of sudden cardiac death.
Pediatr Clin North Am. 2004 Oct;51(5):1229-55. doi: 10.1016/j.pcl.2004.04.012.
8
Connexin43 gene transfer reduces ventricular tachycardia susceptibility after myocardial infarction.
J Am Coll Cardiol. 2012 Sep 18;60(12):1103-10. doi: 10.1016/j.jacc.2012.04.042. Epub 2012 Aug 8.
9
Association of KCNQ1, KCNE1, KCNH2 and SCN5A polymorphisms with QTc interval length in a healthy population.
Eur J Hum Genet. 2005 Nov;13(11):1213-22. doi: 10.1038/sj.ejhg.5201489.
10
Sudden death associated with short-QT syndrome linked to mutations in HERG.
Circulation. 2004 Jan 6;109(1):30-5. doi: 10.1161/01.CIR.0000109482.92774.3A. Epub 2003 Dec 15.
引用本文的文献
1
Unipolar morphology-guided critical isthmus emphasis in a patient with scar-related ventricular tachycardia.
HeartRhythm Case Rep. 2024 Jun 21;10(9):656-660. doi: 10.1016/j.hrcr.2024.06.013. eCollection 2024 Sep.
2
New drug discovery of cardiac anti-arrhythmic drugs: insights in animal models.
Sci Rep. 2023 Sep 29;13(1):16420. doi: 10.1038/s41598-023-41942-4.
3
Site-specific prolongation of repolarization prevents postmyocardial infarction tachycardia.
Heart Rhythm O2. 2023 Jun 8;4(7):466-468. doi: 10.1016/j.hroo.2023.06.003. eCollection 2023 Jul.
4
Heterogeneity of Repolarization and Cell-Cell Variability of Cardiomyocyte Remodeling Within the Myocardial Infarction Border Zone Contribute to Arrhythmia Susceptibility.
Circ Arrhythm Electrophysiol. 2023 May;16(5):e011677. doi: 10.1161/CIRCEP.122.011677. Epub 2023 May 2.
5
Effects of Cardiac Stem Cell on Postinfarction Arrhythmogenic Substrate.
Int J Mol Sci. 2022 Dec 19;23(24):16211. doi: 10.3390/ijms232416211.
6
Repolarization Heterogeneity in Human Post-Infarct Ventricular Tachycardia.
JACC Clin Electrophysiol. 2022 Jun;8(6):713-718. doi: 10.1016/j.jacep.2022.03.002.
7
Animal Models to Study Cardiac Arrhythmias.
Circ Res. 2022 Jun 10;130(12):1926-1964. doi: 10.1161/CIRCRESAHA.122.320258. Epub 2022 Jun 9.
8
Heterogeneous repolarization creates ventricular tachycardia circuits in healed myocardial infarction scar.
Nat Commun. 2022 Feb 11;13(1):830. doi: 10.1038/s41467-022-28418-1.
9
Engineered bacterial voltage-gated sodium channel platform for cardiac gene therapy.
Nat Commun. 2022 Feb 2;13(1):620. doi: 10.1038/s41467-022-28251-6.
10
Ventricular Arrhythmias in Ischemic Cardiomyopathy-New Avenues for Mechanism-Guided Treatment.
Cells. 2021 Oct 1;10(10):2629. doi: 10.3390/cells10102629.
本文引用的文献
1
Complications associated with implantable cardioverter-defibrillator replacement in response to device advisories.
JAMA. 2006 Apr 26;295(16):1907-11. doi: 10.1001/jama.295.16.1907.
2
Pacemaker and ICD generator malfunctions: analysis of Food and Drug Administration annual reports.
JAMA. 2006 Apr 26;295(16):1901-6. doi: 10.1001/jama.295.16.1901.
3
In vivo gene transfer of Kv1.5 normalizes action potential duration and shortens QT interval in mice with long QT phenotype.
Am J Physiol Heart Circ Physiol. 2003 Jul;285(1):H194-203. doi: 10.1152/ajpheart.00971.2002.
4
Expression and function of a biological pacemaker in canine heart.
Circulation. 2003 Mar 4;107(8):1106-9. doi: 10.1161/01.cir.0000059939.97249.2c.
5
Biological pacemaker created by gene transfer.
Nature. 2002 Sep 12;419(6903):132-3. doi: 10.1038/419132b.
6
Focal modification of electrical conduction in the heart by viral gene transfer.
Nat Med. 2000 Dec;6(12):1395-8. doi: 10.1038/82214.
7
Radiofrequency catheter ablation of postinfarction ventricular tachycardia: long-term success and the significance of inducible nonclinical arrhythmias.
Circulation. 1997 Nov 18;96(10):3499-508. doi: 10.1161/01.cir.96.10.3499.
8
Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors.
Nat Genet. 1997 Nov;17(3):314-7. doi: 10.1038/ng1197-314.
9
Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors.
Nat Genet. 1997 Jul;16(3):270-6. doi: 10.1038/ng0797-270.
10
Avoidance of immune response prolongs expression of genes delivered to the adult rat myocardium by replication-defective adenovirus.
Circulation. 1996 Sep 15;94(6):1394-401. doi: 10.1161/01.cir.94.6.1394.
Zotero 插件